刚刚！波士顿科学、史赛克资深管理者，加盟微创医疗旗下！

医疗器械商业评论01-04

来源：医疗器械商业评论昨日（2026年1月3日），微创脑科学（MicroPort NeuroScientific）通过其海外社交媒体宣布，正式任命 Ben Barnes 为 MicroPort NeuroTech America 北美区副总裁兼总经理，全面主导北美市场战略落地与销售体系构建。微创脑科学表示，Ben Barnes统筹将北美业务发展三大核心任务：1）制定并执行区域战略规划；2）搭建...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2600047694?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-04 14:23","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2600047694","market":"us","top_or_hot":-1,"title":"刚刚！波士顿科学、史赛克资深管理者，加盟微创医疗旗下！","media":"医疗器械商业评论","content":"<div>\n<p>来源：医疗器械商业评论昨日（2026年1月3日），微创脑科学（MicroPort NeuroScientific）通过其海外社交媒体宣布，正式任命 Ben Barnes 为 MicroPort NeuroTech America 北美区副总裁兼总经理，全面主导北美市场战略落地与销售体系构建。微创脑科学表示，Ben Barnes统筹将北美业务发展三大核心任务：1）制定并执行区域战略规划；2）搭建...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104145643a6f0ee6a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>刚刚！波士顿科学、史赛克资深管理者，加盟微创医疗旗下！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n刚刚！波士顿科学、史赛克资深管理者，加盟微创医疗旗下！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-04 14:23 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104145643a6f0ee6a&s=b><strong>医疗器械商业评论</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>来源：医疗器械商业评论昨日（2026年1月3日），微创脑科学（MicroPort NeuroScientific）通过其海外社交媒体宣布，正式任命 Ben Barnes 为 MicroPort NeuroTech America 北美区副总裁兼总经理，全面主导北美市场战略落地与销售体系构建。微创脑科学表示，Ben Barnes统筹将北美业务发展三大核心任务：1）制定并执行区域战略规划；2）搭建...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104145643a6f0ee6a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYK","symbol_name":"史赛克","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104145643a6f0ee6a&s=b","article_id":"2600047694","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104145643a6f0ee6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2600047694","pubTimestamp":1767507790,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"微创脑科学表示，Ben Barnes统筹将北美业务发展三大核心任务：1）制定并执行区域战略规划；2）搭建高效能销售组织架构；3）深化客户关系管理与服务支持。Ben Barnes 的职业生涯始于波士顿科学，从区域销售经理起步；其后加入史赛克，担任医学教育与销售培训总监。随着微创脑科学在创新神经介入技术领域的持续突破，Ben Barnes的加盟有望加速其\"中国智造、全球应用\"的战略落地，为全球患者提供更优解决方案。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SYK":"史赛克","SG9999001176.USD":"United Global Healthcare Acc USD","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1153585028.USD":"BGF GLOBAL LONG-HORIZON EQUITY  \"A4\" (USD) INC","BSX":"波士顿科学","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK4581":"高盛持仓","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","BK4585":"ETF&股票定投概念","LU0823417653.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) ACC","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","LU0048584097.USD":"FIDELITY FUNDS  GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) INC","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4504":"桥水持仓","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","BK4588":"碎股","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc"},"translate_title":"Just now! Senior managers of Boston Scientific and Stryker join Minimally Invasive Medical!","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYK":1.5,"BSX":1.5},"content_text":"来源：医疗器械商业评论昨日（2026年1月3日），微创脑科学（MicroPort NeuroScientific）通过其海外社交媒体宣布，正式任命 Ben Barnes 为 MicroPort NeuroTech America 北美区副总裁兼总经理，全面主导北美市场战略落地与销售体系构建。微创脑科学表示，Ben Barnes统筹将北美业务发展三大核心任务：1）制定并执行区域战略规划；2）搭建高效能销售组织架构；3）深化客户关系管理与服务支持。公司特别强调，他在医疗技术领域拥有超过25年的管理经验，曾任职于全球领先的医疗器械企业及创新型初创公司，尤其在神经血管领域具备深厚的商业化、战略拓展与团队建设专长。Ben Barnes 的职业生涯始于波士顿科学（2001-2012），从区域销售经理起步；其后加入史赛克（2013-2020），担任医学教育与销售培训总监。2020年至今，他担任 Neuro Advisors 总裁，该公司专注于为早期及高增长阶段的医疗器械企业提供战略支持，服务涵盖融资规划、商业化上市、运营管理、产品线布局及人才体系建设等方面。在Neuro Advisors任职总裁期间，Ben Barnes主导的代表性项目充分展现其战略纵深能力：NXT STIM（2024年至今）协助优化神经调控领域的美国商业化路径，并推动安全轮融资，以支持其创新市场进入计划。Piraeus Medical（2023年至今）与首席执行官及董事会协作，制定整体营销战略与全球商业化方案。Kaneka Medical（2020-2023）由顾问转为全职总经理，全面负责业务运营。Longeviti Neuro Solutions（2020-2022）初期以顾问身份参与，后出任销售总监，推动销售体系建设。Ben Barnes兼具全球视野与本土化执行能力，其过往有着在神经血管领域从产品组合规划到培训体系搭建，从融资策略设计到团队发展路径的成功经验。随着微创脑科学在创新神经介入技术领域的持续突破，Ben Barnes的加盟有望加速其\"中国智造、全球应用\"的战略落地，为全球患者提供更优解决方案。本文内容仅供参考，不构成投资建议，望读者有效甄别。如有平台转载本篇文章，须自行对该篇文章负责，医疗器械商业评论不对转载引起的二次传播影响负责。*广告推荐阅读HOT年底限时特惠269元！点击图片 直达购买如果您觉得内容有所收获，欢迎星标、点赞、转发！您的支持是我们最大的动力点分享点收藏点在看点点赞","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2600047694","isCrawlerRequest":true}